References

[1]  Cassell MM, et al Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ (Int Ed) 2006; 332: 605–607.

[2]  Novak DP, Karlsson RB. Gender differed factors affecting male condom use. A population-based study of 18-year-old Swedish adolescents. Int J Adolesc Med Health 2005; 17: 379–90.
| CrossRef |

[3]  Roye CF. Condom use by Hispanic and African-American adolescent girls who use hormonal contraception. J Adolesc Health 1998; 23: 205–11.
| CrossRef | CAS |

[4]  Sangi-Haghpeykar H, Posner SF, Poindexter AN. Consistency of condom use among low-income hormonal contraceptive users. Perspect Sex Reprod Health 2005; 37: 184–91.
| CrossRef |

[5]  Sieving R, et al Cognitive and behavioral predictors of sexually transmitted disease risk behavior among sexually active adolescents. Arch Pediatr Adolesc Med 1997; 151: 243–51.
| CAS |

[6]  Smith JL, et al Young males’ perspectives on pregnancy, fatherhood and condom use: where does responsibility for birth control lie? Sex Reprod Healthc 2011; 2: 37–42.
| CrossRef |

[7]  Weisman CS, et al Consistency of condom use for disease prevention among adolescent users of oral contraceptives. Fam Plann Perspect 1991; 23: 71–4.
| CrossRef | CAS |

[8]  Cates W, Holmes KK, Sparling PF, Mardh P. Contraception, contraceptive technology, and STDs. Sex Transm Dis 1999; 3: 1067–78.

[9]  Rosenthal SL, et al Experience with side effects and health risks associated with Norplant implant use in adolescents. Contraception 1995; 52: 283–5.
| CrossRef | CAS |

[10]  Pruitt SL, et al Condom use among sterilized and nonsterilized women in county jail and residential treatment centers. Womens Health Issues 2010; 20: 386–93.
| CrossRef |

[11]  Sangi-Haghpeykar H, Horth F, Poindexter AN. Condom use among sterilized and nonsterilized Hispanic women. Sex Transm Dis 2001; 28: 546–51.
| CrossRef | CAS |

[12]  Semaan S, Lauby J, Walls C. Condom use with main partners by sterilized and non-sterilized women. Women Health Issues 1997; 25: 65–85.
| CrossRef | CAS |

[13]  Behets F, et al Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. Sex Transm Infect 2005; 81: 472–6.
| CrossRef | CAS |

[14]  Behets FM, et al Evidence-based planning of a randomized controlled trial on diaphragm use for prevention of sexually transmitted infections. Sex Transm Dis 2008; 35: 238–42.
| CrossRef |

[15]  Gallo MF, et al Assessment of changes in condom use among female sex workers in a prospective cohort study introducing diaphragm use for disease prevention. Am J Epidemiol 2010; 172: 606–12.
| CrossRef |

[16]  Padian NS, et al Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370: 251–61.
| CrossRef |

[17]  Posner SF, et al Introducing diaphragms into the mix: what happens to male condom use patterns? AIDS Behav 2005; 9: 443–9.
| CrossRef |

[18]  van der Straten A, et al The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav 2009; 13: 564–72.
| CrossRef |

[19]  van der Straten A, Cheng H, Minnis AM. Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe. J Int AIDS Soc 2010; 13: 39–49.
| CrossRef |

[20]  Bukusi EA, et al Adherence to diaphragm use for infection prevention: a prospective study of female sex workers in Kenya. Infect Dis Obstet Gynecol 2009; 2009: 420196.
| CrossRef |

[21]  Belzer M, et al Advance supply of emergency contraception: a randomized trial in adolescent mothers. J Pediatr Adolesc Gynecol 2005; 18: 347–54.
| CrossRef |

[22]  Chin-Quee DS, et al Bridging emergency contraceptive pill users to regular contraception: results from a randomized trial in Jamaica. Contraception 2010; 81: 133–9.
| CrossRef |

[23]  Ekstrand M, et al Advance provision of emergency contraceptive pills reduces treatment delay: a randomised controlled trial among Swedish teenage girls. Acta Obstet Gynecol Scand 2008; 87: 354–9.
| CrossRef |

[24]  Ellertson C, et al Emergency contraception: randomized comparison of advance provision and information only. Obstet Gynecol 2001; 98: 570–5.
| CrossRef | CAS |

[25]  Gray RH, et al Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369: 657–66.
| CrossRef |

[26]  Polis CB, et al Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol 2007; 110: 1379–88.
| CrossRef |

[27]  Walker DM, et al Emergency contraception use is correlated with increased condom use among adolescents: results from Mexico. J Adolesc Health 2004; 35: 329–34.
| CrossRef |

[28]  Eaton LA, Kalichman SC. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep 2007; 4: 165–72.
| CrossRef |

[29]  Potts MH, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, et al Reassessing HIV prevention. Science 2008; 320: 749–50.
| CrossRef | CAS |

[30]  Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000; 14: 2361–70.
| CrossRef | CAS |

[31]  Reynolds SJ, et al Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 2004; 363: 1039–40.
| CrossRef |

[32]  Riess TH, et al “When I was circumcised I was taught certain things”: risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya. PLoS ONE 2010; 5: e12366.
| CrossRef |

[33]  Andersson KM, Owens DK, Paltiel AD. Scaling up circumcision programs in southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission. AIDS Behav 2011; 15: 938–48.
| CrossRef |

[34]  Agot KE, et al Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr 2007; 44: 66–70.
| CrossRef |

[35]  Auvert B, et al Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2: e298.
| CrossRef |

[36]  Bailey RC, et al Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643–56.
| CrossRef |

[37]  Ramjee G, et al Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Res Ther 2007; 4: 20–29.
| CrossRef |

[38]  Foss AM, et al Shifts in condom use following microbicide introduction: should we be concerned? AIDS 2003; 17: 1227–37.
| CrossRef |

[39]  Guest G, et al Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis. AIDS Educ Prev 2007; 19: 310–20.
| CrossRef |

[40]  Holmes WR, Maher L, Rosenthal SL. Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health 2008; 5: 273–8.
| CrossRef |

[41]  McMahon JM, et al Potential impact of vaginal microbicides on HIV risk among women with primary heterosexual partners. J Assoc Nurses AIDS Care 2011; 22: 9–16.
| CrossRef |

[42]  Chen FH. The impact of microbicides and changes in condom usage on HIV prevalence in men and women. AIDS 2006; 20: 1551–3.
| CrossRef |

[43]  Lurie MN, et al The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis 2003; 30: 149–56.
| CrossRef |

[44]  Sanders S, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012; 9: 81–95.

[45]  Newman PA, et al Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Serv Res 2009; 44: 2167–79.
| CrossRef |

[46]  Blower SM, McLean AR. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science 1994; 265: 1451–4.
| CrossRef | CAS |

[47]  Jackson DJ, et al Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS 1995; 9: 1279–84.
| CrossRef | CAS |

[48]  Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. J Acquir Immune Defic Syndr 1997; 16: 266–71.
| CrossRef | CAS |

[49]  Blower S, Schwartz EJ, Mills J. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev 2003; 5: 113–25.
| CAS |

[50]  Newman PA, et al Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come? AIDS Patient Care STDS 2004; 18: 691–701.
| CrossRef |

[51]  Fonseca MGP, et al Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV. PLoS ONE 2010; 5: e11736–11736.
| CrossRef |

[52]  Andersson KM, et al Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: a South African example. J Acquir Immune Defic Syndr 2007; 46: 78–90.

[53]  Newman PA, et al Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr 2004; 37: 1393–403.
| CrossRef |

[54]  Newman PA, et al HIV risk and prevention in a post-vaccine context. Vaccine 2004; 22: 1954–63.
| CrossRef |

[55]  Suraratdecha C, et al The private demand for an AIDS vaccine in Thailand. Health Policy 2005; 71: 271–87.
| CrossRef |

[56]  Suhadev M, et al Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses 2009; 25: 217–24.
| CrossRef |

[57]  Crosby RA, Holtgrave DR. Will sexual risk behaviour increase after being vaccinated for AIDS? Int J STD AIDS 2006; 17: 180–4.
| CrossRef |

[58]  Bartholow BN, et al HIV sexual risk behavior over 36 months of follow-up in the world’s first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39: 90–101.
| CrossRef |

[59]  Guest G, et al HIV vaccine efficacy trial participation: men who have sex with men’s experiences of risk reduction counselling and perceptions of risk behaviour change. AIDS Care 2005; 17: 46–57.
| CrossRef | CAS |

[60]  Newman PA, et al Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Vaccine 2010; 28: 958–64.
| CrossRef | CAS |

[61]  Lee SJ, et al HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach. AIDS Care 2008; 20: 1161–8.
| CrossRef |

[62]  Newman PA, et al Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial. Vaccine 2008; 26: 1091–7.
| CrossRef |

[63]  Nyamathi AM, et al Perceptions of a community sample about participation in future HIV vaccine trials in south India. AIDS Behav 2007; 11: 619–27.
| CrossRef |

[64]  Crosby RA, Holtgrave D. Will sexual risk behavior increase after being vaccinated for AIDS? Int J STD AIDS 2006; 17: 180–4.
| CrossRef |

[65]  Sayles JN, et al Future HIV vaccine acceptability among young adults in South Africa. Health Educ Behav 2010; 37: 193–210.
| CrossRef |

[66]  Newman PA, et al HIV risk and prevention in a post-vaccine context. Vaccine 2004; 22: 1954–63.
| CrossRef |

[67]  Lampinen TM, et al Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine. Canadian Medical Association Journal 2005; 172: 479–83.
| CrossRef |

[68]  van Griensven F, et al Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS 2004; 18: 295–301.
| CrossRef |

[69]  Francis DP, et al Candidate HIV/AIDS vaccines: lessons learned from the world’s first phase III efficacy trials. AIDS 2003; 17: 147–56.
| CrossRef |

[70]  Bishai D, et al Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bull World Health Organ 2004; 82: 652–60.

[71]  Crosby R, et al A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: a randomized controlled trial. Am J Public Health 2009; 99: S96–103.
| CrossRef |

[72]  Darbes L, et al The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS 2008; 22: 1177–94.
| CrossRef |

[73]  Dilley JW, et al Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors. J Acquir Immune Defic Syndr 2007; 44: 569–77.
| CrossRef |

[74]  Jemmott LS, Jemmott JB, O’Leary A. Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health 2007; 97: 1034–40.
| CrossRef |

[75]  Jones KT, et al Evaluation of an HIV prevention intervention adapted for Black men who have sex with men. Am J Public Health 2008; 98: 1043–50.
| CrossRef |

[76]  Lyles CM, et al Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health 2007; 97: 133–43.
| CrossRef |

[77]  Rietmeijer CA. Risk reduction counselling for prevention of sexually transmitted infections: how it works and how to make it work. Sex Transm Infect 2007; 83: 2–9.
| CrossRef | CAS |

[78]  Ward H. One-to-one counselling for STI prevention: not so much whether as how. Sex Transm Infect 2007; 83: 1.

[79]  U.S. Preventative Services Task Force Behavioral counseling to prevent sexually transmitted infections: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 491–6.

[80]  Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 2004; 364: 41–50.
| CrossRef | CAS |